Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. healthcare management
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • Older

Healthcare Management Articles & Analysis

154 news found

Ace Therapeutics Announces Vaccine Development Services Against Superbugs

Ace Therapeutics Announces Vaccine Development Services Against Superbugs

“Our team at Ace Therapeutics is committed to advancing the field of biotechnology to address emerging challenges in healthcare,” said the marketing manager of Ace Therapeutics. “With our vaccine development services, we are excited to offer a proactive approach to combatting superbugs and reducing the threat of antibiotic resistance. ...

ByAce Therapeutics


AI Stocks Targeting Opportunities in the Global Healthcare Market (OTCQB: AVAI) (NASDAQ: NVDA) (NYSE: DELL) (NASDAQ: OTRK)

AI Stocks Targeting Opportunities in the Global Healthcare Market (OTCQB: AVAI) (NASDAQ: NVDA) (NYSE: DELL) (NASDAQ: OTRK)

From data to diagnostics and imaging, drug development and discovery, early intervention and predictive analytics, remote patient monitoring and robotics, AI is revolutionizing healthcare as we know it. Betting on healthcare as a key market, Avant Technologies, Inc. ...

ByInvestorideas.com


Implicity Joins the AWS ISV Accelerate Program

Implicity Joins the AWS ISV Accelerate Program

Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has joined the Amazon Web Services (AWS) Independent Software Vendor (ISV) Accelerate Program, a co-sell program for AWS partners that provide software solutions that run on or integrate with AWS. ...

ByImplicity


Amerigo Scientific Rolls Out Real-Time PCR Kits to Facilitate HAV Research

Amerigo Scientific Rolls Out Real-Time PCR Kits to Facilitate HAV Research

Overall, the HAV Real-TM PCR kit offers a sensitive, specific, and rapid method for the detection of the Hepatitis A virus, assisting healthcare professionals in the diagnosis and management of HAV infections. ...

ByAmerigo Scientific


FREE Webinar – QCS Audit Masterclass: How to use audit effectively

FREE Webinar – QCS Audit Masterclass: How to use audit effectively

She is a qualified adult nurse and has previously held operational leadership roles including, registered manager, regional support manager, regional clinical quality manager, head of quality and director of health. ...

ByQuality Compliance Systems Ltd (QCS)


Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100 Blood Volume Diagnostic for Heart Failure Patients

Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100 Blood Volume Diagnostic for Heart Failure Patients

The site in Mississippi is a community-based facility providing care to patients in five counties in northeast Mississippi and three counties in southern Tennessee, while the fifth hospital, located on the Gulf Coast of Florida, has more than 900 physicians and other healthcare professionals. It is a well-respected heart health research institute, which also participates in ...

ByDaxor Corporation


New Study Confirms Daxor’s BVA-100 Volume Metric Compared to CardioMEMS Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients

New Study Confirms Daxor’s BVA-100 Volume Metric Compared to CardioMEMS Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients

” “Clinicians often rely on pressure monitoring alone to guide HF management by utilizing pressure measures as surrogates of volume status. This study confirms the significant body of evidence that pressure measurements are not adequate substitutes for direct measurements of circulating volume and that both metrics add valuable but different clinical data for the ...

ByDaxor Corporation


Pilot Randomized Controlled Trial Validates Daxor BVA-100 Diagnostic for Heart Failure Patients

Pilot Randomized Controlled Trial Validates Daxor BVA-100 Diagnostic for Heart Failure Patients

Jonathan Feldschuh, Daxor’s Chief Scientific Officer continued, “This pilot study, which was not powered for clinical endpoints but rather feasibility and demonstration of clinical need, exceeded all expectations. Heart failure management is centered around precise volume and red cell management, and this first-of-its-kind RCT adds further validation ...

ByDaxor Corporation


Daxor Corporation Appoints Linda Cooper, Vice President Project Management

Daxor Corporation Appoints Linda Cooper, Vice President Project Management

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the appointment of Linda Cooper as Vice President of Project Management. “Linda joins Daxor with over 30 years of experience in product development and commercialization in the medical device industry. ...

ByDaxor Corporation


Apollo Medical Holdings, Inc. Releases Statement on the Mass Shooting in Monterey Park, Calif.

Apollo Medical Holdings, Inc. Releases Statement on the Mass Shooting in Monterey Park, Calif.

("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today released a statement regarding the mass shooting incident that took place in Monterey Park, Calif., the evening of January 21, ...

ByApollo Medical Holdings, Inc.


Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member

Daxor Corporation Joins the Heart Failure Society of America (HFSA) as a Corporate Member

Daxor’s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. ...

ByDaxor Corporation


Apollo Medical Holdings, Inc. Announces APA ACO Achieved $48.8 Million in Shared Savings from Centers for Medicare and Medicaid Services for 2021 Performance Year

Apollo Medical Holdings, Inc. Announces APA ACO Achieved $48.8 Million in Shared Savings from Centers for Medicare and Medicaid Services for 2021 Performance Year

We truly believe that our continued ability to deliver leading results in healthcare delivery for Original Medicare patients across the country is validation of ApolloMed's physician-centric, tech-enabled, value-based care model. This is, at its core, a superior level of care coordination and population health management that allows our providers to deliver ...

ByApollo Medical Holdings, Inc.


Testing Your Bone Density for Osteoporosis Awareness Month

Testing Your Bone Density for Osteoporosis Awareness Month

When it comes to osteoporosis, testing of bone density and management of these issues is key. This is a widespread disease that affects over ten million Americans. Manage your healthcare with the use of HEDIS (Healthcare Effectiveness Data and Information Set) and OMW (Osteoporosis Management in Women). ...

ByBeamMed Inc.


Newly Published Study Proves Value and CliNewly Published Study Proves Value and Clinical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluationnical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluation of Heart Failure

Newly Published Study Proves Value and CliNewly Published Study Proves Value and Clinical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluationnical Benefit of Daxor’s Blood Volume (BVA-100) Diagnostic in the Evaluation of Heart Failure

Pressures, as a proxy measure, are sometimes used in guiding volume management decisions by clinicians. Data from the study demonstrated a lack of correlation between pressure measures and actual blood volume, highlighting the need for direct and 98% accurate volume measurement that the BVA-100 blood test provides. ...

ByDaxor Corporation


Apollo Medical Holdings, Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference

Apollo Medical Holdings, Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference

Morgan Healthcare Conference on Wednesday, January 11, 2023, at 1:30 p.m. PT/4:30 p.m. ET. "Being part of the JPM healthcare community for the second year in a row is very exciting to us as a growing team and organization. ...

ByApollo Medical Holdings, Inc.


Lumos Pharma to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

Lumos Pharma to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and received early funding from leading healthcare investors, including Deerfield Management, a fund managed by Blackstone Life Sciences, Roche Venture Fund, New Enterprise Associates (NEA), Santé ...

ByLumos Pharma


Partnership of BC Platforms, Euformatics, and Oncompass Medicine, Selected to Deliver Standardized Oncology NGS Workflows for Seven Major European Hospitals

Partnership of BC Platforms, Euformatics, and Oncompass Medicine, Selected to Deliver Standardized Oncology NGS Workflows for Seven Major European Hospitals

BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced that, together with Finland’s Euformatics and Hungary’s Oncompass Medicine, the BCP-led partnership has now successfully been awarded contract for the second phase of developing standardized oncology workflows for a buyer consortium of seven leading ...

ByBC Platforms


Lumos Pharma to Host KOL Webinar to Discuss Interim Phase 2 Data from OraGrowtH Trials in PGHD

Lumos Pharma to Host KOL Webinar to Discuss Interim Phase 2 Data from OraGrowtH Trials in PGHD

Lumos Pharma was founded and is led by a management team with longstanding experience in rare disease drug development and received early funding from leading healthcare investors, including Deerfield Management, a fund managed by Blackstone Life Sciences, Roche Venture Fund, New Enterprise Associates (NEA), Santé ...

ByLumos Pharma


Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference

Lumos Pharma to Participate in the Piper Sandler 34th Annual Healthcare Conference

(NASDAQ:LUMO), a biopharmaceutical company advancing a novel oral therapeutic candidate, LUM-201, through Phase 2 clinical trials for Pediatric Growth Hormone Deficiency (PGHD), announced that the Company will present and host one-on-one meetings at the Piper Sandler 34th Annual Healthcare Conference November 29th through December 1st. Event: Piper Sandler 34th Annual ...

ByLumos Pharma


Purpose-building a new ‘digital twin’ for asset management

Purpose-building a new ‘digital twin’ for asset management

To add to the confusion and clutter, outside of asset management, the term digital twin is used widely as technology companies work to revolutionise everything from healthcare and facilities management, to manufacturing, construction, defence and science. ...

ByTrendspek Pty Ltd

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT